Who are Ortho-Preserve's investors?

Ortho-Preserve's investors include Atlanta Technology Angels.

How much funding has Ortho-Preserve raised?

Ortho-Preserve has disclosed $207K raised across 2 rounds.

Where is Ortho-Preserve headquartered?

Ortho-Preserve is headquartered in Henrico, US.

Ortho-Preserve

Henrico, US · Founded 2021 · 1 known investors

Find your way into Ortho-Preserve

233 people in our graph share verified history with the Ortho-Preserve team — schools, employers, funds. One of them is your warm intro.

Guillaume Baxterunlockedknows Jonathan Schwartz · together at Solvay (overlapped)

×9knows the team · via Solvay

×2knows the team · via MiMedx

OrthoPreserve develops a minimally invasive meniscus implant for orthopedic care, designed to address unmet clinical needs in knee surgery. The company is co-founded by orthopedic clinicians and engineers with expertise across R&D, manufacturing, regulatory compliance, and surgical practice.

Biotech Healthtech Medical Devices

Founders & leadership

Jonathan Schwartz Co-FounderJonathan Schwartz is CEO and co-founder of OrthoPreserve, a medical device company developing a meniscus implant for knee surgery. He brings experience in R&D, product design, manufacturing, and operations within the medical device and biomaterials sectors.

Cyrus KumpChief Medical Officer

Investors · 1

Atlanta Technology Angelslisted by Atlanta Technology AngelsAtlanta · $200K – $2M

Reported raises · per SEC filings

Form D private placements

$207K disclosed across 2 rounds · 2024–2025

▶$157KraisedDec 2025 · 3 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Jonathan William SchwartzExecutive Officer, Director
David Max GuillotDirector
Cyrus Scott KumpExecutive Officer, Director

Offering amount: $2M
Amount sold: $157K
First sale: Dec 2025
Incorporated: Corporation, Delaware, 2025
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$50KraisedOct 2024 · 2 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Jonathan SchwartzExecutive Officer, Director
Cyrus KumpExecutive Officer, Director

Offering amount: $2M
Amount sold: $50K
First sale: Oct 2024
Incorporated: Corporation, Virginia, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2023	$303.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Ortho-Preserve do?: OrthoPreserve develops a minimally invasive meniscus implant for orthopedic care, designed to address unmet clinical needs in knee surgery. The company is co-founded by orthopedic clinicians and engineers with expertise across R&D, manufacturing, regulatory compliance, and surgical practice.
Who are Ortho-Preserve's investors?: Ortho-Preserve's investors include Atlanta Technology Angels.
How much funding has Ortho-Preserve raised?: Ortho-Preserve has disclosed $207K raised across 2 rounds.
Where is Ortho-Preserve headquartered?: Ortho-Preserve is headquartered in Henrico, US.